Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction by Igor Puzanov, Suthee Rapisuwon, Leora Horn, Bridgette A. Kanz, Megan H. Pollack, Romany Johnpulle, Alicia Morgans, Jeffrey A. Sosman, R. Martin Conry, Zeynep Eroglu, Douglas B. Johnson

Get full text

611 XTX202–01/02–001, Phase 1/2 first-in human study of XTX202, a masked, tumor-activated IL-2βγ, in patients with advanced solid tumors: results from phase 1 by David Miller, John Powderly, Suthee Rapisuwon, Sanjay Goel, Bartosz Chmielowski, Richard Wu, Meredith McKean, Damiano Fantini, Yousef Zakharia, Jacob Thomas, Diana Hanna, Anthony El-Khoueiry, Ekta Patel, Anurag Gupta, George Lee, Meghan Duncan, Meredith Pelster, Randy Hurley, Aika Siu, David Crowe, Sattanathan Paramasivan, Katarina Luptakova